Coxibs and cardiovascular disease. [N Engl J Med. 2004] - PubMed

Review COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease. [Pharmacoepidemiol Drug Saf. 2003]
Review COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J. Pharmacoepidemiol Drug Saf. 2003 Jan-Feb; 12(1):67-70.
COX-2 inhibitors--a lesson in unexpected problems. [N Engl J Med. 2005]
COX-2 inhibitors--a lesson in unexpected problems.
Drazen JM. N Engl J Med. 2005 Mar 17; 352(11):1131-2. Epub 2005 Feb 15.
Review The coxibs, selective inhibitors of cyclooxygenase-2. [N Engl J Med. 2001]
Review The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA, Patrono C. N Engl J Med. 2001 Aug 9; 345(6):433-42.
COX-2 inhibitors--lessons in drug safety. [N Engl J Med. 2005]
COX-2 inhibitors--lessons in drug safety.
Psaty BM, Furberg CD. N Engl J Med. 2005 Mar 17; 352(11):1133-5. Epub 2005 Feb 15.
Review Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. [J Clin Invest. 2001]
Review Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.
Patrono C, Patrignani P, García Rodríguez LA. J Clin Invest. 2001 Jul; 108(1):7-13.

Translational research: current status, challenges and future strategies. [Am J Transl Res. 2011]
Translational research: current status, challenges and future strategies.
Yu D. Am J Transl Res. 2011; 3(5):422-33. Epub 2011 Sep 12.
Prostacyclin: an inflammatory paradox. [Front Pharmacol. 2011]
Prostacyclin: an inflammatory paradox.
Stitham J, Midgett C, Martin KA, Hwa J. Front Pharmacol. 2011; 2:24. Epub 2011 May 13.
Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis. [Mol Biol Cell. 2011]
Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis.
Turner EC, Mulvaney EP, Reid HM, Kinsella BT. Mol Biol Cell. 2011 Aug 1; 22(15):2664-79. Epub 2011 Jun 8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Coxibs and cardiovascular disease.
Coxibs and cardiovascular disease.
N Engl J Med. 2004 Oct 21 ;351(17):1709-11. Epub 2004 Oct 6 .

PubMed
The sad story of Vioxx, and what we should learn from it.
The sad story of Vioxx, and what we should learn from it.
Cleve Clin J Med. 2004 Dec ;71(12):933-4, 936, 938-9.

PubMed
Expression of concern reaffirmed.
Expression of concern reaffirmed.
N Engl J Med. 2006 Mar 16 ;354(11):1193. Epub 2006 Feb 22 .

PubMed
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac sur...
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.
N Engl J Med. 2005 Mar 17 ;352(11):1081-91. Epub 2005 Feb 15 .

PubMed
Raising the safety bar--the FDA's coxib meeting.
Raising the safety bar--the FDA's coxib meeting.
N Engl J Med. 2005 Mar 31 ;352(13):1283-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed